MX379302B - Lagrima artificial de gelificacion termo-responsiva. - Google Patents

Lagrima artificial de gelificacion termo-responsiva.

Info

Publication number
MX379302B
MX379302B MX2019015717A MX2019015717A MX379302B MX 379302 B MX379302 B MX 379302B MX 2019015717 A MX2019015717 A MX 2019015717A MX 2019015717 A MX2019015717 A MX 2019015717A MX 379302 B MX379302 B MX 379302B
Authority
MX
Mexico
Prior art keywords
composition
gelification
thermo
responsive
artificial tear
Prior art date
Application number
MX2019015717A
Other languages
English (en)
Spanish (es)
Inventor
Ayaka YAMAMURO
Emi IZUKURA
Moto KIMURA
Takeshi Yamamura
Tomohiro Otsuka
Original Assignee
Wakamoto Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharma Co Ltd filed Critical Wakamoto Pharma Co Ltd
Publication of MX379302B publication Critical patent/MX379302B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
MX2019015717A 2017-04-25 2018-04-25 Lagrima artificial de gelificacion termo-responsiva. MX379302B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017086512 2017-04-25
JP2017249891 2017-12-26
PCT/JP2018/016854 WO2018199180A1 (ja) 2017-04-25 2018-04-25 熱ゲル化人工涙液

Publications (1)

Publication Number Publication Date
MX379302B true MX379302B (es) 2025-03-11

Family

ID=63919901

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019015717A MX379302B (es) 2017-04-25 2018-04-25 Lagrima artificial de gelificacion termo-responsiva.
MX2018014935A MX2018014935A (es) 2017-04-25 2018-04-25 Lagrima artificial de gelificacion termo-responsiva.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2018014935A MX2018014935A (es) 2017-04-25 2018-04-25 Lagrima artificial de gelificacion termo-responsiva.

Country Status (16)

Country Link
US (2) US10532026B2 (cg-RX-API-DMAC10.html)
EP (1) EP3593806B1 (cg-RX-API-DMAC10.html)
JP (2) JP6473274B1 (cg-RX-API-DMAC10.html)
KR (2) KR102083253B1 (cg-RX-API-DMAC10.html)
CN (2) CN110913867B (cg-RX-API-DMAC10.html)
AU (1) AU2018257301B2 (cg-RX-API-DMAC10.html)
BR (1) BR112019018368B1 (cg-RX-API-DMAC10.html)
CA (1) CA3025567C (cg-RX-API-DMAC10.html)
ES (1) ES2912289T3 (cg-RX-API-DMAC10.html)
MX (2) MX379302B (cg-RX-API-DMAC10.html)
MY (2) MY196565A (cg-RX-API-DMAC10.html)
PH (1) PH12019502335A1 (cg-RX-API-DMAC10.html)
RU (1) RU2710366C1 (cg-RX-API-DMAC10.html)
SG (1) SG11201909170QA (cg-RX-API-DMAC10.html)
TW (1) TWI733019B (cg-RX-API-DMAC10.html)
WO (1) WO2018199180A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202007977RA (en) * 2018-02-28 2020-09-29 Santen Pharmaceutical Co Ltd Ophthalmic composition comprising diquafosol and cationic polymer
TW202000196A (zh) * 2018-03-01 2020-01-01 日商石原產業股份有限公司 保存安定性優異之醫藥組成物
WO2020175525A1 (ja) * 2019-02-27 2020-09-03 参天製薬株式会社 ジクアホソルまたはその塩、ビニル系高分子およびセルロース系高分子を含有する眼科用組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2125060C (en) * 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
JP3450805B2 (ja) * 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
JP2003095924A (ja) * 2001-07-16 2003-04-03 Wakamoto Pharmaceut Co Ltd 熱ゲル化人工涙液
GB0210794D0 (en) * 2002-05-10 2002-06-19 Chart Heat Exchangers Ltd Heat exchangers
JP4263456B2 (ja) 2002-03-18 2009-05-13 わかもと製薬株式会社 ヒアルロン酸含有熱ゲル化製剤
JP4263418B2 (ja) * 2002-03-18 2009-05-13 わかもと製薬株式会社 熱ゲル化人工涙液
EP1681065A4 (en) 2003-10-31 2011-12-28 Wakamoto Pharma Co Ltd WATER-BASED COMPOSITION SUBJECTED TO REVERSIBLE THERMOREGULATION
JP5649261B2 (ja) * 2004-05-07 2015-01-07 ロート製薬株式会社 高粘度点眼剤
JP5661981B2 (ja) * 2004-11-26 2015-01-28 大正製薬株式会社 眼科用剤
CN101784287B (zh) * 2007-06-26 2013-04-24 若素制药株式会社 水性组合物

Also Published As

Publication number Publication date
MX2018014935A (es) 2019-04-09
KR102281853B1 (ko) 2021-07-23
WO2018199180A1 (ja) 2018-11-01
EP3593806A4 (en) 2020-03-25
CN113332233B (zh) 2022-02-25
EP3593806B1 (en) 2022-03-30
JPWO2018199180A1 (ja) 2019-06-27
BR112019018368A2 (pt) 2020-04-07
MY196323A (en) 2023-03-24
KR20190110624A (ko) 2019-09-30
TW201842900A (zh) 2018-12-16
ES2912289T3 (es) 2022-05-25
KR102083253B1 (ko) 2020-03-02
RU2710366C1 (ru) 2019-12-26
PH12019502335A1 (en) 2020-09-14
JP6473274B1 (ja) 2019-02-20
CN113332233A (zh) 2021-09-03
AU2018257301A1 (en) 2019-08-22
KR20200020999A (ko) 2020-02-26
JP6736705B2 (ja) 2020-08-05
BR112019018368B1 (pt) 2021-03-02
CN110913867B (zh) 2021-06-11
US20180360746A1 (en) 2018-12-20
MY196565A (en) 2023-04-19
JP2019104740A (ja) 2019-06-27
CA3025567C (en) 2019-10-22
US20200121592A1 (en) 2020-04-23
AU2018257301B2 (en) 2019-10-31
CN110913867A (zh) 2020-03-24
US11096889B2 (en) 2021-08-24
SG11201909170QA (en) 2019-11-28
TWI733019B (zh) 2021-07-11
CA3025567A1 (en) 2018-11-01
EP3593806A1 (en) 2020-01-15
US10532026B2 (en) 2020-01-14

Similar Documents

Publication Publication Date Title
MX2023003124A (es) Composiciones farmaceuticas oftalmicas y usos que se relacionan a las mismas.
CA3285799A1 (en) Artificial tear, contact lens and drug vehicle compositions and methods of use thereof
MX382534B (es) Composicion oftalmologica
CL2020002252A1 (es) Formulación oftálmica.
EP2996172A3 (en) Biocompatibility of biomedical energization elements
MY197845A (en) Pharmaceutical composition
BR112015022161A2 (pt) implante intraocular contendo prostamida
MY190011A (en) Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier
MX367461B (es) Lagrimas artificiales que comprenden hialuronato de sodio y carboximetilcelulosa.
SG11202008901WA (en) Ophthalmic compositions, and ocular uses thereof, of indigo carmine
PH12019502335A1 (en) Thermo-responsive gelling artificial lacrima
MX377637B (es) Composiciones blanqueadoras de cuidado bucal.
IL251019B (en) Ocular formulations for drug administration and protection of the front part of the eye
TR201713929A2 (tr) Ki̇tosan ve alji̇natin hemostati̇k kompozi̇syonlari
GEP20237486B (en) Formulations of copanlisib
EA202191684A1 (ru) Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии
PH12016502386B1 (en) Oral care compositions
MX2017015835A (es) Gel oftalmico de bimatoprost aplicable en gotas.
DK3720428T3 (da) Oftalmisk topisk sammensætning omfattende dobesilsyre til behandling af sygdomme i det bageste øjensegment
EA201501130A1 (ru) Офтальмологическая фармацевтическая композиция
SA520411478B1 (ar) تركيبة لاستكمال الكالسيوم
MX2019008288A (es) Composicion farmaceutica de disgregacion rapida.
PH12016502527A1 (en) Stabilized desmopressin
WO2019078791A3 (en) Shape memory tubular retractor and self-expanding graft- coated nitinol tubular retractor arrangement
IT201700048653A1 (it) Composti supramolecolari costituiti da acido ialuronico, sodio, amminoacidi essenziali (o non essenziali), acido linoleico, licopene e revestradiolo.